Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.
In Advances in biomarker sciences and technology
Zhang Luoping, Guo Helen
2020
ACE2, Angiotensin-converting enzyme 2, ACEI, Angiotensin-converting enzyme inhibitor, AI, Artificial intelligence, AIOD-CRISPR, All-In-One Dual CRISPR-Cas12a, ARB, Angiotensin receptor blocker, ARDS, Acute respiratory distress syndrome, COVID, COVID-19, Coronavirus disease 2019, CQ, Chloroquine, CT, Computed tomography, Coronavirus, DC, Dendritic cell, Detection, Diagnosis, ELISA, Enzyme-linked immunosorbent assay, EUA, Emergency use authorization, FDA, U.S. Food and Drug Administration, GenOMICC, Genetics of Mortality in Critical Care, HCQ, Hydroxychloroquine, LFAs, Lateral flow assays, LSPR, Localized surface plasmon resonance, MERS, Middle East respiratory syndrome, ML, Machine learning, NIAID, U.S. National Institute of Allergy and Infectious Diseases, NIH, National Institutes of Health, PAC-MAN, Prophylactic Antiviral CRISPR in huMAN cells, PCR, Polymerase chain reaction, PCT, Procalcitonin, Prevention, Prognosis, RT-PCR, Reverse transcription polymerase chain reaction, SARS, Severe acute respiratory syndrome, SARS-CoV-2, SARS coronavirus type 2, SaaS, Software as a Service, TCM, Traditional Chinese medicine, Treatment, UCB, University of California Berkeley, UCSF, University of California San Francisco, cDNA, Complementary DNA, mAb, Monoclonal antibody
Weekly Summary
Receive a weekly summary and discussion of the top papers of the week by leading researchers in the field.